Results 1 to 10 of about 18,201 (217)
Modern methods of the treatment of hereditary epidermolysis bullosa
Today there are no ethiopathogenetic treatment methods for treating hereditary epidermolysis bullosa. All available treatment methods are symptomatic and are mainly aimed at patient care.
A. A. Kubanov +3 more
doaj +2 more sources
Circulating anti-type VII collagen autoantibodies are frequently detected in patients with recessive dystrophic epidermolysis bullosa (RDEB). However, evidence supporting their pathogenic role in inducing epidermolysis bullosa acquisita (EBA) has been ...
Liliana Guerra +6 more
doaj +1 more source
Management of epidermolysis bullosa simplex in pregnancy: A case report
Epidermolysis bullosa (EB) encompasses a group of diseases characterized by extreme fragility of skin and mucous membranes, resulting in blister formation following minimal injury.
Nidhi Shah +2 more
doaj +1 more source
Epidermolysis bullosa acquisita
A 20 year old male started developing bubae following even minor trauma on the skin as well as the mucous membranes during the preceding 5 years. The bunae healed with atrophic scars. Involvement of the oral mucous membrane and the eyes, scpcially the right eye, was quite extensive and unusual.
Jayanta Kr, Das +2 more
openaire +2 more sources
Case Report: Effective treatment of dystrophic epidermolysis bullosa pruriginosa with tofacitinib
Epidermolysis bullosa (EB) is a heterogeneous group of hereditary skin diseases caused by mutations in structural proteins at the dermal-epidermal junction.
Fang Sun, Zhenzhen Wu, Zhenze Yu
doaj +1 more source
A pathogenic COL7A1 variant highlights semi-dominant inheritance in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa is a rare subtype of inherited epidermolysis bullosa, caused by variants in the collagen type VII alpha 1 chain (COL7A1) gene (MIM120120).
Saira Sattar +6 more
doaj +1 more source
Introduction: Secondary thrombocytosis is a well-recognized response to chronic inflammation, infections, and systemic disorders, but its association with dermatologic diseases such as Norwegian scabies and epidermolysis bullosa is rare.
Mine Ezgi Payaslı +3 more
doaj +1 more source
Real‐World Experience With Oleogel‐S10 for Wounds in Epidermolysis Bullosa
Background Oleogel‐S10 is the first approved drug for the treatment of wounds in patients with junctional and dystrophic epidermolysis bullosa. Results from the clinical trials, early access programme and open‐label study are available, showing good ...
Miodrag Davidovic +2 more
doaj +1 more source
Sang Trieutien,1,* Tam Vu Van,2,3,* My Tran Ngoc Thao,4 Son Trinh The,5 Khoa Tran Van,1 Tung Nguyen Thanh,5 Tuan Tran Van,5 Hanh Nguyen Thi6 1Department of Biology and Genetics, Vietnam Military Medical University, Hanoi, 12108, Vietnam ...
Trieutien S +7 more
doaj
Pretibial epidermolysis bullosa
A 47-year-old Vietnamese woman presented with dystrophic fingernails and toenails that had been present since infancy. She also had developed, in the third decade, pretibial pruritus with vesicle formation and progressive localized papules and scars. Multiple family members were similarly affected.
Rizzo, Carina +6 more
openaire +4 more sources

